SG Americas Securities
INDV icon

SG Americas Securities’s Indivior Pharmaceuticals INDV Stock Holding History

SG Americas Securities’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Buy
324,134
+300,144
+1,251% +$10.9M 0.01% 736
2026
Q1 		$731K Sell
23,990
-388,207
-94% -$12.8M ﹤0.01% 1958
2025
Q4 		$14.8M Buy
412,197
+363,829
+752% +$11.1M 0.02% 607
2025
Q3 		$1.17M Buy
48,368
+12,162
+34% +$255K ﹤0.01% 1320
2025
Q2 		$534K Buy
+36,206
New +$422K ﹤0.01% 1634

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities's INDV Position: Q2 2026 in Review

SG Americas Securities increased its Indivior Pharmaceuticals (INDV) stake by 1,251% in Q2 2026, buying an estimated $10.9M and bringing the position to 324,134 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #736.

SG Americas Securities first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.8M in Q4 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • SG Americas Securities held 324,134 shares of Indivior Pharmaceuticals worth $13.3M as of Q2 2026.
  • SG Americas Securities bought 300,144 Indivior Pharmaceuticals shares in Q2 2026, an estimated $10.9M.
  • Indivior Pharmaceuticals made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #736 holding.
  • SG Americas Securities first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • SG Americas Securities's Indivior Pharmaceuticals position peaked at $14.8M in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.